Cargando…

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon

BACKGROUND: Due to the prevalence of HIV-1 group M and the endemicity of HIV-1 group O infections in Cameroon, patients may be infected with both viruses and/or with HIV-1/MO recombinant forms. Such atypical infections may be deleterious in terms of diagnosis and therapeutic management due to the hi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Oliveira, Fabienne, Mourez, Thomas, Vessiere, Aurélia, Ngoupo, Paul-Alain, Alessandri-Gradt, Elodie, Simon, François, Rousset, Dominique, Plantier, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237259/
https://www.ncbi.nlm.nih.gov/pubmed/28086923
http://dx.doi.org/10.1186/s12977-016-0324-3
_version_ 1782495499054481408
author De Oliveira, Fabienne
Mourez, Thomas
Vessiere, Aurélia
Ngoupo, Paul-Alain
Alessandri-Gradt, Elodie
Simon, François
Rousset, Dominique
Plantier, Jean-Christophe
author_facet De Oliveira, Fabienne
Mourez, Thomas
Vessiere, Aurélia
Ngoupo, Paul-Alain
Alessandri-Gradt, Elodie
Simon, François
Rousset, Dominique
Plantier, Jean-Christophe
author_sort De Oliveira, Fabienne
collection PubMed
description BACKGROUND: Due to the prevalence of HIV-1 group M and the endemicity of HIV-1 group O infections in Cameroon, patients may be infected with both viruses and/or with HIV-1/MO recombinant forms. Such atypical infections may be deleterious in terms of diagnosis and therapeutic management due to the high divergence of HIV-1/O. The aim of this study was to identify prospectively such atypical infections in Cameroon. RESULTS: Based on serological screening by env-V3 serotyping and a molecular strategy using group-specific (RT)-PCRs, we identified 10 Cameroonian patients harboring three different profiles of infection: (1) 4 HIV-1/M + O dual infections without evidence of recombinant; (2) 5 recombinants associated with one or both parental strains; and (3) 1 new recombinant form without parental strains. CONCLUSIONS: This work highlights the dynamic co-evolution of these two HIV groups in Cameroon that could lead to the emergence of a circulating recombinant form MO, and the need for accurate identification of such atypical infections for precise diagnosis, virological monitoring and therapeutic management with adapted tools.
format Online
Article
Text
id pubmed-5237259
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52372592017-01-18 Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon De Oliveira, Fabienne Mourez, Thomas Vessiere, Aurélia Ngoupo, Paul-Alain Alessandri-Gradt, Elodie Simon, François Rousset, Dominique Plantier, Jean-Christophe Retrovirology Research BACKGROUND: Due to the prevalence of HIV-1 group M and the endemicity of HIV-1 group O infections in Cameroon, patients may be infected with both viruses and/or with HIV-1/MO recombinant forms. Such atypical infections may be deleterious in terms of diagnosis and therapeutic management due to the high divergence of HIV-1/O. The aim of this study was to identify prospectively such atypical infections in Cameroon. RESULTS: Based on serological screening by env-V3 serotyping and a molecular strategy using group-specific (RT)-PCRs, we identified 10 Cameroonian patients harboring three different profiles of infection: (1) 4 HIV-1/M + O dual infections without evidence of recombinant; (2) 5 recombinants associated with one or both parental strains; and (3) 1 new recombinant form without parental strains. CONCLUSIONS: This work highlights the dynamic co-evolution of these two HIV groups in Cameroon that could lead to the emergence of a circulating recombinant form MO, and the need for accurate identification of such atypical infections for precise diagnosis, virological monitoring and therapeutic management with adapted tools. BioMed Central 2017-01-13 /pmc/articles/PMC5237259/ /pubmed/28086923 http://dx.doi.org/10.1186/s12977-016-0324-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
De Oliveira, Fabienne
Mourez, Thomas
Vessiere, Aurélia
Ngoupo, Paul-Alain
Alessandri-Gradt, Elodie
Simon, François
Rousset, Dominique
Plantier, Jean-Christophe
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title_full Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title_fullStr Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title_full_unstemmed Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title_short Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon
title_sort multiple hiv-1/m + hiv-1/o dual infections and new hiv-1/mo inter-group recombinant forms detected in cameroon
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237259/
https://www.ncbi.nlm.nih.gov/pubmed/28086923
http://dx.doi.org/10.1186/s12977-016-0324-3
work_keys_str_mv AT deoliveirafabienne multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT mourezthomas multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT vessiereaurelia multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT ngoupopaulalain multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT alessandrigradtelodie multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT simonfrancois multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT roussetdominique multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon
AT plantierjeanchristophe multiplehiv1mhiv1odualinfectionsandnewhiv1mointergrouprecombinantformsdetectedincameroon